Trial intelligence / Profile preview

SAMURAI Study of E3810 in Japanese Subjects With Functional Dyspepsia

jRCT2080221232Phase 2

Sponsor
Eisai Co., Ltd.
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of lucitanib in functional dyspepsia (FD), sponsored by Eisai Co., Ltd.

02

Drugs

lucitanib
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on jRCT2080221232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call